Zetonna (Ciclesonide) Patent Expiration, LOE Window & CMS Spending

Zetonna (Ciclesonide) by Covis: FDA Orange Book LOE 2028-02-01, 0 AB generics, $372K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCovis
FDA Application & PathwayN202129 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2028-02-01
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$372K
2024 Medicare Part D Spend$236K
2024 Medicaid Spend$136K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel